Serotonin News and Research

Latest Serotonin News and Research

Chemical pathways of serotonin in the nervous system pave way for future pharmaceutical treatments for depression

From mollusks to mammals, newly discovered chemical pathways of serotonin in the nervous system are paving a path toward future pharmaceutical treatments for depression and other disorders.

10 Sep 2004

Cymbalta approved for diabetic peripheral neuropathy pain

The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.

8 Sep 2004

Cymbalta, treatment for major depression hits the market

Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company has announced.

26 Aug 2004

Cymbalta, a new treatment for major depression

Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company have announced.

25 Aug 2004

Genetic mutation link to sudden infant death syndrome

Researchers at Rush University Medical Center, and colleagues at the University of Pittsburgh have identified mutations in genes pertinent to the autonomic nervous system among babies who died of sudden infant death syndrome (SIDS) that might explain why they died.

21 Aug 2004

Current information on the use of antidepressants in pediatric patients

The Food and Drug Administration has issued an update to provide health care providers and patients with the most current information on the use of antidepressants in pediatric patients.

21 Aug 2004

Pineal gland which regulates the cycles of sleep and waking evolved to improve vision

The pineal gland - which regulates the cycles of sleep and waking - appears to have evolved as an indirect way to improve vision, by keeping toxic compounds away from the eye

13 Aug 2004

Newborns may be harmed when pregnant women take Selective Serotonin Re-uptake Inhibitors (SSRIs) and other anti-depressants during the third trimester of pregnancy

Health Canada is advising Canadians that newborns may be adversely affected when pregnant women take Selective Serotonin Re-uptake Inhibitors (SSRIs) and other newer anti-depressants during the third trimester of pregnancy.

9 Aug 2004

Approval of Cymbalta for treatment of major depressive disorder

The U.S. Food and Drug Administration has approved Cymbalta® (duloxetine HCl; pronounced SIM-BALL-TA), judging it a safe and effective treatment for major depressive disorder, Eli Lilly and Company have announced.

5 Aug 2004

Overactive brain circuit brings on depression

A brain imaging study by the NIH's National Institute of Mental Health (NIMH) has found that an emotion-regulating brain circuit is overactive in people prone to depression – even when they are not depressed.

5 Aug 2004

Molecular pathway in the brain may explain why some patients suffering from inflammatory diseases develop depression

Feeling sick can be "all in the head" for people with inflammatory disorders or for those receiving immunotherapy, say Robert Dantzer and Keith Kelley, professors in the department of animal sciences at the University of Illinois at Urbana-Champaign.

29 Jul 2004

Study to begin to develop patient guidelines for the use of antidepressant medications in pregnancy and following birth

The University of Arizona department of psychiatry is conducting a first-of-its kind study to begin to develop patient guidelines for the use of antidepressant medications in pregnancy and following birth.

21 Jul 2004

Suicidal behavior is higher in the first month after starting antidepressants

A new study in the current issue of The Journal of the American Medical Association reports that the risk of suicidal behavior is higher in the first month after starting antidepressants.

20 Jul 2004

Possible cure for sudden infant death syndrome (SIDS)

University of Chicago researchers may have found a crucial clue to understanding and ultimately eliminating sudden infant death syndrome, the leading cause of post-neonatal mortality in the United States.

9 Jul 2004

Identification of a naturally occurring genetic difference that controls the production of serotonin in the brain

Researchers at Duke University Medical Center have provided the first direct evidence in mice for the role of an enzyme that specifically controls the production of serotonin in the brain.

8 Jul 2004

An EU-funded research project will help to uncover the genetic factors linked to depression to develop new drug treatments

120 million people worldwide suffer from depression. An EU-funded research project launched recently will help to uncover the genetic factors linked to depression to develop new drug treatments.

29 Jun 2004

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Data presented today at the 3rd International Consultation on Incontinence, provide evidence for the efficacy of duloxetine, an investigational agent for the treatment of women with stress urinary incontinence (SUI).

29 Jun 2004

Drug combination reduces cocaine use

Researchers at the Yerkes National Primate Research Center are the first to demonstrate that a combination of drug therapies targeting the region of the brain that controls drug abuse and addiction significantly reduces cocaine use in nonhuman primates.

15 Jun 2004

Canadians advised of stronger warnings for selective serotonin re-uptake inhibitors and other newer anti-depressants

Health Canada is advising Canadians that Selective Serotonin Re-uptake Inhibitors (SSRIs) and other newer anti-depressants, now carry stronger warnings. These new warnings indicate that patients of all ages taking these drugs may experience behavioural and/or emotional changes that may put them at increased risk of self-harm or harm to others.

11 Jun 2004

Gene mutation found in some women may decrease effectiveness of tamoxifen breast cancer drug

Researchers from the Johns Hopkins Kimmel Cancer Center, Indiana University and the University of Michigan have found that some women have a gene mutation that may decrease the effectiveness of tamoxifen, a commonly used breast cancer drug.

7 Jun 2004

Serotonin News and Research

Latest Serotonin News and Research

Chemical pathways of serotonin in the nervous system pave way for future pharmaceutical treatments for depression

Cymbalta approved for diabetic peripheral neuropathy pain

Cymbalta, treatment for major depression hits the market

Cymbalta, a new treatment for major depression

Genetic mutation link to sudden infant death syndrome

Current information on the use of antidepressants in pediatric patients

Pineal gland which regulates the cycles of sleep and waking evolved to improve vision

Newborns may be harmed when pregnant women take Selective Serotonin Re-uptake Inhibitors (SSRIs) and other anti-depressants during the third trimester of pregnancy

Approval of Cymbalta for treatment of major depressive disorder

Overactive brain circuit brings on depression

Molecular pathway in the brain may explain why some patients suffering from inflammatory diseases develop depression

Study to begin to develop patient guidelines for the use of antidepressant medications in pregnancy and following birth

Suicidal behavior is higher in the first month after starting antidepressants

Possible cure for sudden infant death syndrome (SIDS)

Identification of a naturally occurring genetic difference that controls the production of serotonin in the brain

An EU-funded research project will help to uncover the genetic factors linked to depression to develop new drug treatments

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Drug combination reduces cocaine use

Canadians advised of stronger warnings for selective serotonin re-uptake inhibitors and other newer anti-depressants

Gene mutation found in some women may decrease effectiveness of tamoxifen breast cancer drug

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Serotonin News and Research

Latest Serotonin News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in